A programmatic strategy aimed at supporting the capacity of the Unit to network on thematic areas impacting directly on its ability to deliver solutions tailored to the needs of Member States has resulted in the development of a new CRP aimed at driving innovations. The sub-Programme is in the process of empanelling the CRP, Enhancing the Efficiency of Induced Mutagenesis through an Integrated Biotechnology Pipeline.